Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan

NCT02254837 is registered in ClinicalTrials.gov with Cook Group Incorporated as lead sponsor.

NCT NCT02254837
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02254837 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Zilver PTX Post-Market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan
Lead sponsor
Cook Group Incorporated
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2012
Completion date
June 30, 2018
Enrollment
909 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

peripheral arterial disease (pad)